"ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory" was originally created and published by ...

TOLEDO, Ohio — The Toledo Assembly Complex will add a third vehicle to its production lineup, Stellantis announced on Tuesday. The vehicle, a midsize truck, will join the facility's Jeep Gladiator and ...

TG Therapeutics, Inc. (NASDAQ: TGTX) Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a new subcutaneous route of administration for Saphnelo (anifrolumab), used as an add-on ...

November 6, 2025 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2025 Highlights Announcement of Genmab’s proposed acquisition of Merus N.V. (Merus)Genmab revenue increased ...

What prompted a lifetime in stitches? Not the humorous kind - the painful sort. Was it worth it or, as that unsisterly ...

Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

Federal immigration authorities plan to significantly boost staffing at a national tip intake center headquartered in Williston. According to federal contracting records posted on October 1, the ...

Johnson & Johnson ( JNJ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 11, 2025 10:30 AM EST ...

UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM ESTCompany ParticipantsAndrew Dickinson - Chief ...